Galileo- An automated synthesis module for development and manufacturing of novel radio-metallic tracers
Erol Bars, Anthony Belanger, Stephen Dragotakes.
Dana Farber Molecular Cancer Imaging Facility (MCIF) & Brigham and Woman’s Hospital (BICOR)
Poster
This Module is under patent revision 2018
could be a presentation if needed
Dana-Farber’s PET research center (Molecular Cancer Imaging Facility, of MCIF) and BICOR at Brigham and Women’s Hospital, both based in Boston Massachusetts, have developed a radio-labeling synthesizer. The unit is capable of adopting multiple configurations and is fully programmable, allowing our research teams to develop novel compounds and synthesis methods in the field of molecular imaging.
This synthesizer has a unique design comprised of modular sub-units that will allow for enhanced flexibility in developing a variety of new cancer radiotracers in an efficient and safe manner.
Molecular imaging is playing a key role in today’s cancers diagnostics. This article describes an overview of a new design concept and methods used to advance research in cancer imaging at a greater pace.
Recent advancements in 3D printing materials bring a new generation of automated process systems to the field of nuclear medicine that will enable us to achieve more efficient and effective methods for discovering novel compounds.
Galileo is a new type of synthesizer named after its original function to process gallium-68. It was constructed entirely by 3D nylon, Aluminum and plastic printing using state-of-the-art technology in Direct Metal Laser Sintering (DMLS), Selective Laser Sintering